MedTrace Logo

The Effect of Core Exercises in Postoperative Scoliosis

NCT07634003 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-06-08

No results posted yet for this study

Summary

This study aims to investigate the effects of a core stabilization-based rehabilitation program following adolescent idiopathic scoliosis (AIS) surgery on radiological parameters, pain, upper extremity function, range of motion, and scapular assessment. Participants diagnosed with AIS and treated with posterior spinal fusion surgery will undergo a rehabilitation program based on core stabilization exercises. Outcome measures will include Cobb angle, vertebral rotation, Visual Analog Scale (VAS), QuickDASH, Trunk Appearance Perception Scale (TAPS), SRS-22, cervical and shoulder range of motion, and scapular assessment tests. Assessments will be conducted before and after the rehabilitation program.

Conditions

  • Adolescent Idiopathic Scoliosis

Interventions

BEHAVIORAL

Core Stabilization-Based Rehabilitation Program

Participants received a core stabilization-based rehabilitation program following adolescent idiopathic scoliosis surgery. The rehabilitation program included core stabilization exercises, postural control training, scapular stabilization exercises, and functional exercise approaches.

Sponsors & Collaborators

  • Hasan Kalyoncu University

    lead OTHER

Principal Investigators

  • Yavuz Yakut, Prof. Dr. · Hasan Kalyoncu University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
10 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-28
Primary Completion
2026-04-30
Completion
2026-04-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07634003 on ClinicalTrials.gov